4.13
price up icon12.53%   0.46
after-market Dopo l'orario di chiusura: 4.10 -0.03 -0.73%
loading
Precedente Chiudi:
$3.67
Aprire:
$3.69
Volume 24 ore:
449.21K
Relative Volume:
0.64
Capitalizzazione di mercato:
$137.10M
Reddito:
-
Utile/perdita netta:
$-86.60M
Rapporto P/E:
-1.4581
EPS:
-2.8324
Flusso di cassa netto:
$-67.37M
1 W Prestazione:
-0.48%
1M Prestazione:
-1.43%
6M Prestazione:
-25.99%
1 anno Prestazione:
-64.97%
Intervallo 1D:
Value
$3.60
$4.14
Intervallo di 1 settimana:
Value
$3.60
$4.2664
Portata 52W:
Value
$1.45
$13.63

Lexeo Therapeutics Inc Stock (LXEO) Company Profile

Name
Nome
Lexeo Therapeutics Inc
Name
Telefono
(212) 547-9879
Name
Indirizzo
345 PARK AVENUE SOUTH, NEW YORK
Name
Dipendente
75
Name
Cinguettio
Name
Prossima data di guadagno
2025-03-24
Name
Ultimi documenti SEC
Name
LXEO's Discussions on Twitter

Confronta LXEO con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
LXEO
Lexeo Therapeutics Inc
4.13 198.11M 0 -86.60M -67.37M -2.8324
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Lexeo Therapeutics Inc Stock (LXEO) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-06-13 Iniziato Robert W. Baird Outperform
2024-06-06 Iniziato H.C. Wainwright Buy
2023-11-28 Iniziato Chardan Capital Markets Buy
2023-11-28 Iniziato JP Morgan Overweight
2023-11-28 Iniziato Leerink Partners Outperform
2023-11-28 Iniziato RBC Capital Mkts Outperform
2023-11-28 Iniziato Stifel Buy
Mostra tutto

Lexeo Therapeutics Inc Borsa (LXEO) Ultime notizie

pulisher
Jul 25, 2025

Lexeo Therapeutics Inc. Stock Analysis and ForecastUnstoppable profit momentum - Autocar Professional

Jul 25, 2025
pulisher
Jul 25, 2025

Is Lexeo Therapeutics Inc. a good long term investmentExtraordinary profit generation - Autocar Professional

Jul 25, 2025
pulisher
Jul 25, 2025

What risks could impact Lexeo Therapeutics Inc. stock performanceDynamic investment growth - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 23, 2025

What drives Lexeo Therapeutics Inc. stock priceFree Stock Market Return Analysis - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Lexeo Therapeutics Inc. stockFree Daily Trading Room Entry - Autocar Professional

Jul 23, 2025
pulisher
Jul 19, 2025

Will Lexeo Therapeutics Inc. stock split in the near futureSafe and Smart Investment Picks - beatles.ru

Jul 19, 2025
pulisher
Jul 18, 2025

Lexeo Therapeutics (NASDAQ:LXEO) & Organogenesis (NASDAQ:ORGO) Head to Head Analysis - Defense World

Jul 18, 2025
pulisher
Jul 18, 2025

What analysts say about Lexeo Therapeutics Inc. stock outlookFree Investment Portfolio Suggestions - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

How high can Lexeo Therapeutics Inc. stock price go in 2025Safe and Smart Investment Picks - Newser

Jul 18, 2025
pulisher
Jul 17, 2025

What makes Lexeo Therapeutics Inc. stock price move sharplyFree Access to Community with 300% Return - beatles.ru

Jul 17, 2025
pulisher
Jul 15, 2025

Why Lexeo Therapeutics Inc. stock attracts strong analyst attentionFree Expert-Led Investment Training - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Lexeo Therapeutics Inc. stock performs during market volatilityCarefully Curated High Return Stocks - Newser

Jul 15, 2025
pulisher
Jul 11, 2025

Lexeo Therapeutics soars 96% following March Fair Value signal By Investing.com - Investing.com South Africa

Jul 11, 2025
pulisher
Jul 11, 2025

Lexeo Therapeutics soars 96% following March Fair Value signal - Investing.com

Jul 11, 2025
pulisher
Jul 07, 2025

Stifel reiterates Buy rating on Lexeo Therapeutics stock at $21 price target - Investing.com Nigeria

Jul 07, 2025
pulisher
Jul 07, 2025

Stifel reiterates Buy rating on Lexeo Therapeutics stock at $21 price target By Investing.com - Investing.com South Africa

Jul 07, 2025
pulisher
Jul 07, 2025

Lexeo Therapeutics stock rises after FDA breakthrough designation By Investing.com - Investing.com Nigeria

Jul 07, 2025
pulisher
Jul 07, 2025

Lexeo Therapeutics Secures FDA Breakthrough Therapy Designation for LX2006, Shares Rise 8% in Pre-market Trade. - AInvest

Jul 07, 2025
pulisher
Jul 07, 2025

Lexeo Therapeutics announces FDA Breakthrough Therapy Designation for LX2006 - TipRanks

Jul 07, 2025
pulisher
Jul 07, 2025

Lexeo Therapeutics Announces FDA Breakthrough Therapy Designation for LX2006 in Friedreich Ataxia Treatment - Nasdaq

Jul 07, 2025
pulisher
Jul 07, 2025

FDA grants breakthrough therapy designation to Lexeo’s FA treatment - Investing.com

Jul 07, 2025
pulisher
Jul 07, 2025

Lexeo Therapeutics Announces FDA Breakthrough Therapy Designation for LX2006 in Friedreich Ataxia - GlobeNewswire

Jul 07, 2025
pulisher
Jul 07, 2025

FDA Breakthrough: Lexeo's Gene Therapy Shows Promise in Fatal Rare Disease Treatment - Stock Titan

Jul 07, 2025
pulisher
Jul 01, 2025

LXEO files 41.6M-share prospectus; $80M raise backs accelerated LX2006 plan | ATNFW SEC FilingForm 8-K - Stock Titan

Jul 01, 2025
pulisher
Jul 01, 2025

LXEO files 41.6M-share prospectus; $80M raise backs accelerated LX2006 plan - Stock Titan

Jul 01, 2025

Lexeo Therapeutics Inc Azioni (LXEO) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Capitalizzazione:     |  Volume (24 ore):